Patents Assigned to Research Development Foundation
  • Patent number: 12293853
    Abstract: Provided herein are composite conductors, characterized by having copper deposits inside the bulk rather than on the outer surface of a non-metallic conductive porous matrix, such as CNT fabric, as well as a process for obtaining the same. The composite conductors provided herein are also characterized by a low specific weight and a high ampacity compared to metal conductors of similar size and shape.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: May 6, 2025
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yair Ein-Eli, Neta Yitzhack, Nina Sezin, David Starosvetsky
  • Publication number: 20250136719
    Abstract: The present invention relates to an heparanase-binding and heparanase-neutralizing monoclonal antibody (IgG-1 mAb A54), including its epitope (HBD-II) and mode of interaction with heparanase, pharmaceutical composition comprising same, and uses thereof e.g. for inhibiting or treating a disease or disorder associated with heparanase activity, including but not limited to cancer, inflammation, viral infection, diabetes and related complications. The present invention further provides combinatorial cancer therapies, comprising the heparanase-neutralizing mAb and an additional anti-cancer treatment such as chemotherapy or radiation.
    Type: Application
    Filed: September 25, 2024
    Publication date: May 1, 2025
    Applicants: Technion Research & Development Foundation Limited, Hadasit Medical Research Services and Development Ltd.
    Inventors: Israel Vlodavsky, Uri Barash
  • Patent number: 12281601
    Abstract: A method for converting heat to mechanical work includes providing incoming heat transfer liquid (HTL) at a first temperature to a plurality of mixing chambers, providing incoming compressed gas at a second temperature to the plurality of mixing chamber, enabling the gas and the HTL to mix, producing a gas-and-HTL mix, enabling the HTL in the gas-and-HTL mix to heat the gas and isothermal expansion of the gas in the gas-and-HTL mix, limiting volume of the gas-and-HTL mix, thereby increasing pressure of the gas and causing acceleration of a flow of the gas-and-HTL mix, causing the gas-and-HTL mix to eject through a plurality of nozzles, thereby converting the heat of the HTL to kinetic energy to cause movement of the plurality of nozzles; and using the kinetic energy to produce mechanical work.
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: April 22, 2025
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Carmel Rotschild, Joseph Cassell
  • Publication number: 20250122854
    Abstract: A direct gaseous reformate injector that includes an inlet for receiving a gaseous reformate; a plunger; and an outward-opening valve that comprises a valve body and a needle that is movable, by the plunger, in relation to the valve body, between a (a) closed position in which the gaseous reformate is not outputted from the direct gaseous reformate injector, and (b) an open position in which the gaseous reformate is outputted from the direct gaseous reformate injector.
    Type: Application
    Filed: October 15, 2024
    Publication date: April 17, 2025
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Leonid Tartakovsky, Asher Netzer Lichinitzer
  • Patent number: 12274678
    Abstract: The present invention provides a pharmaceutical composition including a combination of at least two cannabinoids, and methods of using same, such as for treating a NOTCH 1-related disease.
    Type: Grant
    Filed: May 17, 2020
    Date of Patent: April 15, 2025
    Assignees: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: David Meiri, Elazar Besser, Igal Louria-Hayon, Paula Berman, Gil Moshe Lewitus, Limor Broday
  • Publication number: 20250114351
    Abstract: A method of treating a disease or disorder for which an increase in immune cells in the brain is therapeutic in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which specifically binds and increases activity of a receptor selected from the group consisting of a 5HT2C receptor, a 5HT2A receptor and a 5HT2B receptor in the postcentral gyrus and/or the choroid plexus (CP) of the brain of the subject. Compositions for treating these diseases are also disclosed.
    Type: Application
    Filed: December 18, 2024
    Publication date: April 10, 2025
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Asya ROLLS, Dorit FARFARA, Ben KORIN, Hilla AZULAY-DEBBY, Shahar ARMON
  • Publication number: 20250107703
    Abstract: Exemplary embodiments of the present disclosure include systems and methods for treatment of occlusions, including coronary artery chronic total occlusions.
    Type: Application
    Filed: December 13, 2024
    Publication date: April 3, 2025
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Marc D. FELDMAN, Thomas E. MILNER, Nitesh KATTA, Arnold ESTRADA, Meagan OGLESBY, Andrew Giles CABE, Mehmet CILINGIROGLU
  • Patent number: 12268101
    Abstract: Compositions comprising a) one or more amorphous superconductor layers bound to one or more flexible substrate layers, or b) one or more superconductor layers bound to one or more layers of a high dielectric material are disclosed. Furthermore, provided herein are articles comprising one or more compositions of the invention and method of manufacturing thereof.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: April 1, 2025
    Assignee: TECHNION RESEARCH &DEVELOPMENT FOUNDATION LIMITED
    Inventors: Yachin Ivry, Mohammad Suleiman
  • Publication number: 20250101369
    Abstract: A method of preparing a composition comprising mycelium along with a cellulose and/or plurality of nanoparticles is described herein. The method comprises inoculating a liquid medium with fungus, the liquid medium comprising nutrients and the cellulose and/or nanoparticles. Further described herein are compositions comprising mycelium along with a cellulose and/or plurality of nanoparticles, as well as articles-of-manufacture comprising such a composition, wherein at least 10% of the cellulose and/or nanoparticles in the composition is incorporated within the mycelium. A method of enhancing fungal growth is also described, comprising contacting the fungus with a liquid medium comprising a polymer which comprises carboxylic acid groups.
    Type: Application
    Filed: December 9, 2024
    Publication date: March 27, 2025
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Noam ATTIAS, Jacob GROBMAN, Tiffany ABITBOL
  • Publication number: 20250086788
    Abstract: A method for quantitative magnetic resonance imaging (MRI), the method includes (a) receiving a sequence of MRI images of an in vivo tissue, by an image registration deep neural network (DNN) module that was trained, by a training process, to impose one or more MRI signal related physical constraints on a content of the sequence of MRI images; and (b) extracting one or more quantitative map from the sequence of MRI images.
    Type: Application
    Filed: August 14, 2024
    Publication date: March 13, 2025
    Applicants: Technion Research & Development Foundation Limited, MEDICAL RESEARCH & DEVELOPMENT FUND FOR HEALTH SERVICES, BNAI-ZION MEDICAL CENTER
    Inventors: Mordechay Pinchas Freiman, Eyal Hanania, Israe Cohen
  • Patent number: 12247231
    Abstract: Systems comprising a first polynucleotide comprising a regulatory element operatively linked to an open reading frame encoding an invertase enzyme and a second polynucleotide comprising a repressible regulatory element operatively linked to an open reading frame encoding a glucose oxidase enzyme wherein the repressible element inhibits transcription in response to hydrogen peroxide are provided. Cells and compositions comprising a system of the invention, as well as methods using the system of the invention, are also provided, as is artificial honey.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: March 11, 2025
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Roee Amit, Shira Levi, Lidya Tannenzapf, Yehonatan Zur, Ilan Brajzblat, Assaf Licht, Ofri Warsha, Mai Dror, Dor Ben Meir, Lior Haim, Zeinat Awwad, Nir Litver, Tzila Davidov, Liron Abrahami Pachuk, Noa Eden, Hanriet Tibi, Orna Atar
  • Publication number: 20250079018
    Abstract: A method including sensing local accelerations or changes in sensor position, including orientation and displacement, with a local acceleration sensor mounted on a chest or abdomen of a patient, and calculating energy of polyphasic motions, based on sensed information of the local acceleration sensor and classifying severity of cardiac decompensation by calculating an excessive energy index (EEi) that compares excessive energy that appears in the polyphasic motions to energy required for inspiration at a basic respiratory rate.
    Type: Application
    Filed: November 14, 2024
    Publication date: March 6, 2025
    Applicants: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD., RAMBAM HEALTH CORPORATION
    Inventors: Amir Landesberg, Yakov Tsibulsky, Shmuel Rispler
  • Patent number: 12241776
    Abstract: A system and method of detecting acoustic waves including directing a continuous-wave source laser beam to an optical resonator that is impinged by acoustic the waves. Optionally, the source laser beam can propagate through the optical resonator, thereby generating a propagated laser beam. Using an interferometer, the acoustic waves can be detected by monitoring transients in an optical phase of the propagated laser beam.
    Type: Grant
    Filed: September 19, 2023
    Date of Patent: March 4, 2025
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Amir Rozental, Lucas Riobo, Yoav Hazan
  • Patent number: 12236976
    Abstract: An acoustic feature extraction (AFE) circuit includes a plurality of band-pass filters (BPFs) adaptable to a plurality of channels with different band-pass frequency ranges respectively for switchably receiving an amplified signal, thereby generating corresponding filtered signals, the plurality of BPFs including an operational amplifier that is shared among the plurality of channels; and a rectifier switchably coupled to receive the filtered signals, thereby generating a rectified signal. The amplified signal is time-division demultiplexed onto the BPFs in different phases, and the filtered signals are time-division multiplexed onto the rectifier in different phases.
    Type: Grant
    Filed: May 2, 2024
    Date of Patent: February 25, 2025
    Assignees: NCKU Research and Development Foundation, Himax Technologies Limited
    Inventors: Meng-Ju Chiang, Soon-Jyh Chang
  • Patent number: 12226468
    Abstract: Immunoreactive engineered polypeptides are provided. The engineered polypeptides can be used to diagnose or induce an immune response against E. chaffeensis or E. canis.
    Type: Grant
    Filed: June 26, 2024
    Date of Patent: February 18, 2025
    Assignee: Research Development Foundation
    Inventors: Jere McBride, David Walker
  • Patent number: 12230306
    Abstract: A method, comprising: providing an electrical energy source having a specified amount of electrical energy; connecting an array comprising n magnetic tunnel junctions (MTJ) in parallel to said electrical energy source, wherein each of said MTJs is at a high resistance initial state; discharging said specified energy amount through said MTJs, thereby causing a random subset of said MTJs to switch to a lower resistance state; determining a post-discharging resistance state of each of the MTJs; and assigning a logical state to each of said MTJs corresponding to said resistance state of said MTJ.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: February 18, 2025
    Assignee: TECHNION RESEARCH &DEVELOPMENT FOUNDATION LIMITED
    Inventors: Shahar Kvatinsky, Ben Perach
  • Publication number: 20250051348
    Abstract: Mechanophoric compounds featuring one or more, or two or more, clickable group(s), which are capable of being coupled to naturally occurring, synthetic and/or metallic substrates via Click chemistry, method of preparing mechanophoric matrices using the mechanophoric compounds, and mechanophoric matrices obtainable thereby, and uses thereof for detecting force-induced damage in the matrices by a colorimetric change are provided.
    Type: Application
    Filed: August 13, 2024
    Publication date: February 13, 2025
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Joshua M. GROLMAN, Yifan LIAO, Hang ZHANG, Charles Eliezer DIESENDRUCK
  • Patent number: 12220246
    Abstract: A method comprising: generating a parametrized three-dimensional (3D) body surface model on a training set comprising a plurality of 3D scans of subjects, wherein at least some of said 3D scans are of subjects having a skeletal deformity; receiving one or more target 3D scans of a target subject; optimizing said body surface model with respect to said one or more target 3D scans to calculate a target body surface model of said target subject; training a skeletal estimation model on a training set comprising: (i) body surface models of a plurality of subjects, and (ii) skeletal landmarks sets of said plurality of subjects; and applying said trained skeletal estimation model to said calculated target body surface model of said target subject, to estimate a skeletal shape of said target subject.
    Type: Grant
    Filed: May 1, 2024
    Date of Patent: February 11, 2025
    Assignees: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED, NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY
    Inventors: Ron Kimmel, Benjamin Groisser, Alon Wolf, Roger F. Widmann, Howard J. Hillstrom
  • Publication number: 20250041275
    Abstract: The invention relates generally to the field of compositions including one or more conjugates of di-sugar and a nonsteroidal anti-inflammatory drug (NSAID), and use of same in methods for treating a disease or a disorder in a subject in need thereof.
    Type: Application
    Filed: October 10, 2024
    Publication date: February 6, 2025
    Applicants: RAMBAM MED-TECH LTD., TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Iyad KHAMAYSI, Salim HADAD, Zaid ABASSI
  • Patent number: 12213810
    Abstract: Exemplary embodiments of the present disclosure include apparatus and methods to classify the plaque tissue present in the coronary artery using intravascular optical coherence tomography (IVOCT) images.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: February 4, 2025
    Assignee: Research Development Foundation
    Inventors: Thomas E. Milner, Vikram Lal Baruah, Aydin Zahedivash, Austin McElroy, Marc D. Feldman, Taylor Brent Hoyt